The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 11.50
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.696%)
Open: 12.00
High: 12.00
Low: 12.00
Prev. Close: 12.00
SOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-yearly Report

23 Dec 2008 16:00

Immediate Release: 23rd December 2008

MeDaVinci Plc (`MeDaVinci' or the 'Company') Interim Report For the six months ended 30 September 2008

MeDaVinci (AIM:MVC), the investment Company focussed on technologies, products and services in the health and wellness markets, announces Interim Results for the period ended 30 September 2008.

Chairman's Statement

During the period under review the operating loss was ‚£117,000 compared with ‚£ 137,000 in the corresponding period last year. After interest receivable of ‚£ 64,000 (2007: ‚£36,000) the loss for the period was ‚£53,000.

Your board is currently completing a review of activities which is expected to result in the following actions being taken during 2009:

* The Company will focus its activities on further developing Demecal and Ergodynamics via licensing models. We will no longer pursue our expansion of fitness activities in Hungary and we are currently in discussions to dispose of our interest in Emotion Fitness * The Company will seek to raise further funding in the early part of 2009, this coupled with the disposal of our fitness business will substantially strengthen our balance sheet * International partnerships and collaborations are currently being negotiated with strategic parties, which if successful will greatly enhance the speed of commercialisation

It is our intention to complete the above actions quickly, resulting in a highly focused and well funded business.

Peter TeerlinkChairman23rd December 2008

For further information please contact:

Peter Teerlink, Chairman Tel: 0031 10 288 4343 Rob Westerhof, Chief Executive MeDavinci Plc Adam Reynolds Tel: 020-7245-1100 Hansard Group Hugh Field Tel: 020-7523-8000 Collins Stewart (NOMAD) CONSOLIDATED BALANCE SHEET

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008

Unaudited Unaudited Audited 30 September 30 September 31 March 2008 2007 2008 ‚£'000 ‚£'000 ‚£'000 Assets Non-current assets Property, plant and equipment 7 2 8 Investments in associates 3,429 1,356 3,306 Available for sale financial 40 40 40assets Loans to associates 1,637 652 1,209 Derivative financial instruments- 509 509 509Conversion rights ___________ ___________ ___________ 5,622 2,559 5,072 ___________ ___________ ___________ Current assets Trade and other receivables 120 35 106 Cash and cash equivalents 220 232 730 ___________ ____________ ___________ 340 267 836 ___________ ____________ ___________ Total assets 5,962 2,826 5,908 ___________ ____________ ___________ EQUITY AND LIABILITIES Equity attributable to equity holders of the parent Share capital 736 412 736 Other reserves 5,561 2,613 5,418 Retained earnings (444) (336) (391) ___________ ____________ ___________ Total equity 5,853 2,689 5,763 ___________ ____________ ___________ Current liabilities Trade and other payables 99 137 135 Current tax payable 10 - 10 ___________ ____________ ___________ Total liabilities 109 137 145 ___________ ____________ ___________ Total equity and liabilities 5,962 2,826 5,908 ___________ ____________ ___________

The financial statements were approved and authorised for issue by the board on 23 December 2008 and were signed on its behalf by:-

P TeerlinkDirectorCONSOLIDATED INCOME STATEMENT

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008

Notes Unaudited Unaudited Audited 30 September 30 September 31 March 2008 2007 2008 ‚£'000 ‚£'000 ‚£'000 Revenue - - - Cost of sales - - - ____________ ____________ ___________ Gross profit - - - Administrative expenses (117) (132) (257) Finance income- bank interest 8 14 22 * interest on loan to 56 - 58 associates - Change in fair value of - - 161 derivatives Share of post tax loss of - - (155)associates ____________ ____________ ___________ Loss before taxation (53) (118) (171) Income tax expense - - (2) ____________ ____________ ___________ Loss for the year (53) (118) (173) ____________ ____________ ___________ Earnings per share Basic and diluted 1 (0.07) (0.3) (0.3) ____________ ____________ ___________

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDER EQUITY

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008

Share Share Retained Foreign Associates Total fair value capital premium earnings currency ‚£'000 ‚£'000 ‚£'000 ‚£'000 ‚£'000 reserve ‚£'000 For the period ended 30 September 2008 At 1 April 736 5,305 (391) 594 (481) 5,763 _______ _______ _______ _______ _______ ______ Loss for the period - - (53) - - (53)attributable to equity shareholders Unrealised exchange - - - 143 - 143movement Issue of Shares - - - - - - _______ _______ _______ _______ _______ ______

Movement in period - - (53) 143 - 90

_______ _______ _______ _______ _______ ______

At 30 September 2008 736 5,305 (444) 737 (481) 5,853

_______ _______ _______ _______ _______ ______ For the period ended 30 September 2007 At 1 April 412 2,570 (218) 10 - 2,774 _______ _______ _______ _______ _______ ______ Loss for the period - - (118) - - (118)attributable to equity shareholders Unrealised exchange - - - 33 - 33movement Issue of shares - - - - - - _______ _______ _______ _______ _______ ______

Movement in period - - (118) 33 - (85)

_______ _______ _______ _______ _______ ______

At 30 September 2007 412 2,570 (336) 43 - 2,689

_______ _______ _______ _______ _______ ______ Share Share Retained Foreign Share Total capital premium earnings currency warrants ‚£'000 ‚£'000 ‚£'000 ‚£'000 reserve ‚£'000 ‚£'000 For the year ended 31 March 2008 At 1 April 412 2,570 (218) 10 - 2,774 _______ ______ _______ _______ _______ _______ Profit for the year - - (173) - - 1,318attributable to equity shareholders Fair value - - - - (481) (481)adjustment on investment Unrealised exchange - - - 584 - 584movement Issue of shares 324 2,745 - - - 3,069 Transaction costs - (10) - - - (10)deducted from equity _______ _______ _______ _______ _______ _______ Movement in year 324 2,735 (173) 584 (481) 2,989 _______ _______ _______ _______ _______ _______ At 31 March 2008 736 5,305 (391) 594 (481) 5,763 _______ _______ _______ _______ _______ _______

The authorised, called up and fully paid share capital as at 30 September 2008 relates to 73,600,000 shares at a nominal value of 1 pence each.

CONSOLIDATED STATEMENT OF RECOGNISED INCOME AND EXPENSE

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008

Notes Unaudited Unaudited Audited 30 30 September 31 March September 2007 2008 2008 ‚£'000 ‚£'000 ‚£'000 Loss for the year (53) (118) (173) Net exchange differences on 9 116 33 584translating foreign operations ___________ ___________ __________ Total recognised income and expense 63 (85) 411for the year ___________ ___________ __________ Attributable to equity holders of 63 (85) 411the parent ___________ ___________ __________

CONSOLIDATED CASH FLOW STATEMENT

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2008

Notes Unaudited Unaudited Audited 30 September 30 September 31 March 2008 2007 2008 ‚£'000 ‚£'000 ‚£'000 Cash flows from operating activities Cash generated from operations 2 (110) (59) (82) Interest received 8 36 22 __________ ___________ __________ Net cash flow from operating (102) (23) (60)activities __________ ___________ __________ Cash flows from investing activities Acquisition of investments - - (106) Purchase of property, plant and - (1) (8)equipment (408) - (957)Increase in loans to associates __________ ___________ __________ Net cash flow from investing (408) (1) (1,071)activities __________ ___________ __________ Cash flows from financing activities Proceeds from issue of equity - - 969instruments Costs relating to issue of equity - - -instruments Other loans - (636) - __________ ____________ __________ Net cash flow from financing - 969activities __________ ____________ __________ Net (decrease)/increase in cash (510) (660) (162)and cash equivalents Cash and cash equivalents at 730 892 892beginning of the year __________ ____________ __________ Cash and cash equivalents at end 7 220 232 730of the year __________ ____________ __________ BASIS OF PREPARATION

As is permitted by the AIM Rules, the directors have not adopted the requirements of IAS 34 "Interim Financial Reporting" in preparing the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.

The financial information for the six months ended 30 September 2008 and 30 September 2007 is unaudited and does not constitute statutory accounts within the meaning of Section 240 of the Companies Act 1985.

The comparative figures for the year ended 31 March 2008 were derived from the statutory accounts for that year which have been delivered to the Registrar of Companies. Those accounts received an unqualified audit report which did not contain statements under sections 237(2) or (3) of the Companies Act 1985.

All accounting policies as set out in the annual report and accounts for the year ended 31 March 2008 have been consistently applied to this interim report.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 31 MARCH 2008

1. EARNINGS PER SHARE

Basic

Basic earnings per share is calculated by dividing the profit attributable toequity shareholders by the weighted average number of ordinary shares in issueduring the year. Unaudited Unaudited Audited 30 September 30 September 31 March 2008 2007 2008 ‚£'000 ‚£'000 ‚£'000

Loss attributable to equity holders of (53) (118) (173) the company

_________ _________ __________ Weighted average number of ordinary 73,600 41,188 56,441shares in issue (thousands) _________ _________ __________ Basic earnings per share (pence) (0.07) (0.03) (0.3) _________ _________ __________ Diluted

The Group had no dilutive potential ordinary shares in either year, which would serve to increase the loss per ordinary share. Therefore, there is no difference between the loss per ordinary share and the diluted loss per ordinary share.

2. CASH FLOW FROM OPERATING ACTIVITIES

Unaudited Unaudited Audited 30 September 30 September 31 March 2008 2007 2008 ‚£'000 ‚£'000 ‚£'000 Loss before taxation (53) (118) (171) Depreciation 1 - - Finance income (64) (14) (241) Share of loss in investments in - (5) 155associates _________ _________ __________

Changes in working capital (excluding (116) (137) (257) effect of acquisitions and disposals)

Decrease/(increase) in trade and other 42 73 2receivables Increase in trade and other payables (36) 5 173 __________ __________ __________ Cash outflow from operations (110) (59) (82) __________ __________ __________

vendor
Date   Source Headline
16th Apr 20247:00 amRNSFull Year Trading Update
10th Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSBoard Changes
12th Dec 20237:00 amRNSHalf Year Results
29th Nov 20237:00 amRNSNotice of Results and Investor Presentations
9th Nov 20237:00 amRNSMello Investor Presentation
18th Oct 20237:00 amRNSTrading & Strategic Update
13th Oct 20237:00 amRNSNotice of Trading Update
5th Oct 20232:25 pmRNSHolding(s) in Company
21st Sep 20231:02 pmRNSResult of AGM
25th Aug 20239:45 amRNSNotice of AGM and Posting of Annual Report
11th Jul 20237:00 amRNSFinal Results
4th Jul 20237:00 amRNSNotice of Results and Investor Presentation
17th Apr 20233:13 pmRNSHolding(s) in Company
13th Apr 20232:28 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTrading Update & Progress on Growth Strategy
16th Mar 20237:00 amRNSAppointment of Interim Non-Executive Chairman
3rd Mar 20238:12 amRNSDirector/PDMR Dealing
17th Feb 20233:54 pmRNSResult of Retail Offer
17th Feb 20237:00 amRNSClose of Retail Offer
14th Feb 20232:51 pmRNSHolding(s) in Company
13th Feb 202311:55 amRNSHolding(s) in Company
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:30 pmRNSResult of Placing
8th Feb 20239:16 amRNSRetail Offer
8th Feb 20237:00 amRNSProposed Placing to raise a minimum of £4 million
6th Feb 20237:00 amRNSDeath of Director
23rd Jan 20237:00 amRNSNew Third Party Arrangement
10th Jan 20237:00 amRNSTrading Update
13th Dec 20227:00 amRNSHalf Year Results
17th Nov 20227:00 amRNSNotice of Results and Investor Presentation
15th Nov 20225:25 pmRNSAIM Rule 17 Schedule 2(g) Update
18th Oct 20227:00 amRNSHalf Year Trading Update
15th Sep 20223:24 pmRNSResult of AGM & Notice of Trading Update
22nd Aug 20227:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20227:00 amRNSBoard Changes and Change of Auditor
12th Jul 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Results and Investor Presentation
10th Jun 20223:31 pmRNSDirector/PDMR Shareholding
6th May 202212:55 pmRNSDirector/PDMR Dealing
14th Apr 20227:00 amRNSBoard Appointment
6th Apr 20222:05 pmRNSSecond Price Monitoring Extn
6th Apr 20222:00 pmRNSPrice Monitoring Extension
6th Apr 20227:00 amRNSTrading Update and New Third Party Arrangements
6th Jan 20227:00 amRNSTrading Update
20th Dec 20219:00 amRNSExercise of Warrants and Total Voting Rights
30th Nov 20217:00 amRNSHalf Year Results
12th Nov 20217:00 amRNSNotice of Results
7th Oct 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.